Comparison of fecal inflammatory markers in Crohn's disease
Journal article
Wright, Emily K., Kamm, Michael A., De Cruz, Peter, Hamilton, Amy L., Ritchie, Kathryn J., Keenan, Jacqueline I., Leach, Steven, Burgess, Laura, Aitchison, Alan, Gorelik, Alexandra, Liew, Danny, Day, Andrew S. and Gearry, Richard B.. (2016). Comparison of fecal inflammatory markers in Crohn's disease. Inflammatory Bowel Diseases. 22(5), pp. 1086 - 1094. https://doi.org/10.1097/MIB.0000000000000671
Authors | Wright, Emily K., Kamm, Michael A., De Cruz, Peter, Hamilton, Amy L., Ritchie, Kathryn J., Keenan, Jacqueline I., Leach, Steven, Burgess, Laura, Aitchison, Alan, Gorelik, Alexandra, Liew, Danny, Day, Andrew S. and Gearry, Richard B. |
---|---|
Abstract | Background Fecal biomarkers are used increasingly to monitor Crohn's disease (CD). However, the relative accuracy of different markers in identifying inflammation has been poorly evaluated. We evaluated fecal calprotectin (FC), lactoferrin (FL), and S100A12 (FS) using endoscopic validation in a prospective study of the progression of CD after intestinal resection. Methods Data were collected from 135 participants in a prospective, randomized, controlled trial aimed at preventing postoperative CD recurrence. Three hundred nineteen stool samples were tested for FC, FL, and FS preoperatively and 6, 12, and 18 months after resection. Colonoscopy was performed at 6 and/or 18 months. Endoscopic recurrence was assessed blindly using the Rutgeerts score. C-reactive protein (CRP) and Crohn's Disease Activity Index (CDAI) were assessed. Results FC, FL, and FS concentrations were elevated preoperatively (median: 1347, 40.9, and 8.4 μg/g, respectively). At 6 months postoperatively, marker concentrations decreased (166, 3.0, 0.9 μg/g) and were higher in recurrent disease than remission (275 versus 72 μg/g, P < 0.001; 5.7 versus 1.6 μg/g, P = 0.007; 2.0 versus 0.8 μg/g, P = 0.188). FC > 135 μg/g, FL > 3.4 μg/g, and FS > 10.5 μg/g indicated endoscopic recurrence (score ≥ i2) with a sensitivity, specificity, and negative predictive value (NPV) of 0.87, 0.66, and 91%; 0.70, 0.68, and 81%; 0.91, 0.12, and 71%, respectively. FC and FL correlated significantly with the presence and severity of endoscopic recurrence, whereas FS, CRP and CDAI did not. Conclusions FC was the optimal fecal marker for monitoring disease activity in postoperative CD and was superior to CRP and CDAI. FL offered modest sensitivity for detecting recurrent disease, whereas S100A12 was sensitive but had low specificity and NPV. |
Keywords | calprotectin; lactoferrin; S100A12; postoperative; biomarkers |
Year | 2016 |
Journal | Inflammatory Bowel Diseases |
Journal citation | 22 (5), pp. 1086 - 1094 |
Publisher | Lippincott Williams & Wilkins |
ISSN | 1078-0998 |
Digital Object Identifier (DOI) | https://doi.org/10.1097/MIB.0000000000000671 |
Scopus EID | 2-s2.0-84964888857 |
Page range | 1086 - 1094 |
Publisher's version | File Access Level Controlled |
Place of publication | United States of America |
https://acuresearchbank.acu.edu.au/item/88315/comparison-of-fecal-inflammatory-markers-in-crohn-s-disease
Restricted files
Publisher's version
116
total views0
total downloads1
views this month0
downloads this month